Article

Lassa virus diversity and feasibility for universal prophylactic vaccine

2019-01-31

Abstract excerpt

Lassa virus (LASV) is a highly prevalent mammarenavirus in West Africa and is maintained in nature in a persistently infected rodent host, Mastomys natalensis , which is widely spread in sub-Saharan Africa. LASV infection of humans can cause Lassa fever (LF), a disease associated with high morbidity and significant mortality. Recent evidence indicates an LASV expansion outside its traditional endemic areas. In 201...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 23a65539-760a-5aa1-b1f0-6dca752bbc47
DOI: 10.12688/f1000research.16989.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lassa virus diversity and feasibility for universal prophylactic vaccineDOI 10.12688/f1000research.16989.1Read

Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developmentsSemantic proximity Read

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and developmentSemantic proximity Read

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shotSemantic proximity Read

Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.Semantic proximity Read

Challenges, Progress, and Pathways to Equitable ACCESS in Lassa Fever Vaccine DevelopmentSemantic proximity Read

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsSemantic proximity Read

A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigsSemantic proximity Read

Conglomeration of highly antigenic nucleoproteins to inaugurate a heterosubtypic next generation vaccine candidate against Arenaviridae familySemantic proximity Read

Spatio-temporal spread and evolution of Lassa virus in West AfricaSemantic proximity Read

Design and In Silico Validation of a Novel Multi-Epitopes Subunit Vaccine Candidate against Lassa Virus Using Reverse Vaccinology ApproachSemantic proximity Read

A Mutation-Based Reverse Vaccinology Approach Considering Variability in Epitopes to Combat Multi-Strains: A Study Using Glycoprotein of LASV.Semantic proximity Read

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa virusesSemantic proximity Read